These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11107832)

  • 1. [Complicated therapy of hypertension. The higher the risk, the lower the target blood pressure].
    MMW Fortschr Med; 2000 Nov; 142(45):66-7. PubMed ID: 11107832
    [No Abstract]   [Full Text] [Related]  

  • 2. [7 causes of therapy refractory hypertension].
    Schumacher B
    MMW Fortschr Med; 2006 Mar; 148(13):6, 8. PubMed ID: 16642694
    [No Abstract]   [Full Text] [Related]  

  • 3. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of complicated arterial hypertension].
    Arabidze GG; Bogoslovskiĭ VA
    Ter Arkh; 1982; 54(11):138-48. PubMed ID: 7157166
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2004 May; 145(18):949-56. PubMed ID: 15188641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When blood pressure control is a problem. Refractory hypertension is rare].
    Offers E; Kolloch R
    MMW Fortschr Med; 2002 Nov; 144(46):42-4, 46. PubMed ID: 12534081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood pressure limits for the initiation and goal of antihypertensive therapy. Blood pressure and cardiovascular risk].
    Holzgreve H
    MMW Fortschr Med; 2005 Jun; 147(23):37-8. PubMed ID: 15981903
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination versus Monotherapy as Initial Treatment in Hypertension.
    Holzgreve H
    Herz; 2003 Dec; 28(8):725-32. PubMed ID: 14689107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension 2010: what was new for the cardiologist?
    Gaciong Z; Symonides B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2579-97. PubMed ID: 20977397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accomplish more blood pressure lowering with initial fixed-dose combination therapy.
    Cardiovasc J Afr; 2009; 20(2):153. PubMed ID: 19421660
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of arterial hypertension].
    Demin AA
    Sov Med; 1981; (9):88-94. PubMed ID: 7313801
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension. Individualized treatment as a new therapy concept].
    Düsing R; Vetter H
    Internist (Berl); 1991 Mar; 32(3):135-8. PubMed ID: 2055684
    [No Abstract]   [Full Text] [Related]  

  • 15. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.
    Mancia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Boudier HA; Zanchetti A;
    J Hypertens; 2007 Sep; 25(9):1751-62. PubMed ID: 17762635
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?].
    Schmieder RE
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of combination therapy in treatment of hypertension].
    Kreutz R
    Krankenpfl J; 2005; 43(7-10):255. PubMed ID: 16515324
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.
    Waeber B; Mourad JJ
    Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945
    [No Abstract]   [Full Text] [Related]  

  • 19. How big a role should JNC 7 play in the care of hypertensive patients?
    Weir MR
    J Fam Pract; 2007 May; 56(5):E7-9; author reply E9-10. PubMed ID: 17475158
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.